STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNOW
  4. [Form 4] Snowflake Inc. Insider Trading Activity

Snowflake (NYSE: SNOW) director sells 300K shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Snowflake Inc. (SNOW) director Frank Slootman reported exercising stock options for 300,000 shares of common stock at an exercise price of $8.8800 per share on August 18–19, 2026, and selling 300,000 shares in multiple open-market transactions at weighted-average prices between $318.510 and $334.000 per share. The stock option was fully vested, and all exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025. Some additional Snowflake shares are held indirectly through various family and grantor retained annuity trusts for which Slootman or his spouse acts as trustee.

Positive

  • None.

Negative

  • None.
Insider Slootman Frank
Role Director
Sold 300,000 shs ($97.43M)
Approx. gross sale proceeds $97.43M
Approx. exercise cost $2.66M
Approx. pre-tax spread $94.76M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F26 48,990 $0.00 $0.00
Exercise Common Stock F1, F2 48,990 $8.88 $435K
Sale Common Stock F1, F15, F2 12,662 $319.065 $4.04M
Sale Common Stock F1, F16, F2 18,023 $319.976 $5.77M
Sale Common Stock F1, F17, F2 4,259 $320.888 $1.37M
Sale Common Stock F1, F18, F2 3,988 $321.988 $1.28M
Sale Common Stock F1, F19, F2 3,711 $322.877 $1.20M
Sale Common Stock F1, F20, F2 3,895 $324.128 $1.26M
Sale Common Stock F1, F21, F2 2,392 $324.875 $777K
Sale Common Stock F1, F2 60 $325.82 $20K
Exercise Stock Option (Right to Buy) F1, F26 251,010 $0.00 $0.00
Exercise Common Stock F1, F2 251,010 $8.88 $2.23M
Sale Common Stock F1, F3, F2 11,046 $322.09 $3.56M
Sale Common Stock F1, F4, F2 40,412 $323.244 $13.06M
Sale Common Stock F1, F5, F2 61,332 $324.099 $19.88M
Sale Common Stock F1, F6, F2 42,537 $325.064 $13.83M
Sale Common Stock F1, F7, F2 46,307 $325.958 $15.09M
Sale Common Stock F1, F8, F2 9,137 $327.20 $2.99M
Sale Common Stock F1, F9, F2 6,594 $328.075 $2.16M
Sale Common Stock F1, F10, F2 3,968 $329.007 $1.31M
Sale Common Stock F1, F11, F2 12,003 $330.344 $3.97M
Sale Common Stock F1, F12, F2 10,586 $331.345 $3.51M
Sale Common Stock F1, F13, F2 4,030 $332.42 $1.34M
Sale Common Stock F1, F14, F2 3,058 $333.372 $1.02M
holding Common Stock F22 -- -- --
holding Common Stock F23 -- -- --
holding Common Stock F24 -- -- --
holding Common Stock F25 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 4,436,655 shares (Direct); Common Stock — 28,535 shares (Direct); Common Stock — 207,855 shares (Indirect, Trust)
Footnotes (26)
  1. F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
  2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
  3. F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $321.620 to $322.605, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  4. F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $322.620 to $323.615, inclusive.
  5. F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $323.620 to $324.610, inclusive.
  6. F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $324.620 to $325.617, inclusive.
  7. F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $325.620 to $326.560, inclusive.
  8. F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $326.620 to $327.590, inclusive.
  9. F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $327.725 to $328.660, inclusive.
  10. F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $328.730 to $329.480, inclusive.
  11. F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.860 to $330.830, inclusive.
  12. F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.880 to $331.850, inclusive.
  13. F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.995 to $332.920, inclusive.
  14. F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.200 to $334.000, inclusive.
  15. F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $318.510 to $319.500, inclusive.
  16. F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $319.510 to $320.495, inclusive.
  17. F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $320.520 to $321.510, inclusive.
  18. F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $321.525 to $322.510, inclusive.
  19. F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $322.530 to $323.460, inclusive.
  20. F20. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $323.655 to $324.545, inclusive.
  21. F21. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $324.755 to $325.590, inclusive.
  22. F22. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
  23. F23. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
  24. F24. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
  25. F25. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
  26. F26. The stock option is fully vested.
Options exercised 300000 shares Stock option exercises into Snowflake common stock on August 18–19, 2026
Shares sold 300000 shares Open-market or private sales of Snowflake common stock on August 18–19, 2026
Option exercise price $8.8800 per share Exercise price for stock options converted into common stock
Sale price range $318.510 to $334.000 per share Weighted-average price ranges for reported Snowflake share sales
Rule 10b5-1 plan adoption date September 19, 2025 Date Slootman adopted the trading plan governing these transactions
Net shares sold 300000 shares Net buy/sell direction from transaction summary marked as net-sell
Derivative transactions 2 transactions Stock option exercises reported with code M
Non-derivative sale transactions 20 transactions Common stock sales reported with code S over two days
Rule 10b5-1 trading plan regulatory
"The exercises and sales were effected pursuant to a 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price"
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
Grantor Retained Annuity Trust financial
"2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
restricted stock units financial
"Includes shares to be issued in connection with the vesting of one or more restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

What insider transactions did Frank Slootman report at Snowflake (SNOW)?
Frank Slootman reported exercising stock options for 300,000 shares of Snowflake common stock at $8.8800 per share and selling 300,000 shares of common stock in multiple open-market transactions on August 18–19, 2026.

At what prices were Snowflake (SNOW) shares sold in this Form 4 filing?
The reported Snowflake common stock sales by Frank Slootman used weighted-average prices from multiple trades with sale price ranges between $318.510 and $334.000 per share, as detailed in the individual transaction footnotes.

Were Frank Slootman’s Snowflake (SNOW) trades made under a Rule 10b5-1 plan?
Yes. The filing states that the exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Frank Slootman on September 19, 2025, indicating the transactions followed a pre-arranged trading schedule.

How many Snowflake (SNOW) options did Frank Slootman exercise and at what strike price?
Frank Slootman exercised stock options covering an aggregate of 300,000 shares of Snowflake common stock at an exercise price of $8.8800 per share. The filing also notes that the referenced stock option was fully vested at the time of exercise.

Does Frank Slootman hold Snowflake (SNOW) shares indirectly through trusts?
Yes. The filing notes that certain Snowflake shares are held by several family and Grantor Retained Annuity Trusts, including grandchildren’s and children’s trusts, where Frank Slootman or his spouse serves as trustee.

What is the net effect of this Form 4 on Frank Slootman’s Snowflake (SNOW) share position?
According to the filing’s transaction summary, reported sales totaled 300,000 shares and option exercises also totaled 300,000 shares, resulting in a net-sell of 300,000 shares for this reporting period. Post-transaction share totals are not specified in the data provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Slootman Frank
(Last)(First)(Middle)
C/O SNOWFLAKE INC.
135 CONSTITUTION DRIVE
(Street)
MENLO PARK CALIFORNIA 94025
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Snowflake Inc. [ SNOW ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/18/2026M(1)251,010A$8.88279,545(2)D
Common Stock08/18/2026S(1)11,046D$322.09(3)268,499(2)D
Common Stock08/18/2026S(1)40,412D$323.244(4)228,087(2)D
Common Stock08/18/2026S(1)61,332D$324.099(5)166,755(2)D
Common Stock08/18/2026S(1)42,537D$325.064(6)124,218(2)D
Common Stock08/18/2026S(1)46,307D$325.958(7)77,911(2)D
Common Stock08/18/2026S(1)9,137D$327.2(8)68,774(2)D
Common Stock08/18/2026S(1)6,594D$328.075(9)62,180(2)D
Common Stock08/18/2026S(1)3,968D$329.007(10)58,212(2)D
Common Stock08/18/2026S(1)12,003D$330.344(11)46,209(2)D
Common Stock08/18/2026S(1)10,586D$331.345(12)35,623(2)D
Common Stock08/18/2026S(1)4,030D$332.42(13)31,593(2)D
Common Stock08/18/2026S(1)3,058D$333.372(14)28,535(2)D
Common Stock08/19/2026M(1)48,990A$8.8877,525(2)D
Common Stock08/19/2026S(1)12,662D$319.065(15)64,863(2)D
Common Stock08/19/2026S(1)18,023D$319.976(16)46,840(2)D
Common Stock08/19/2026S(1)4,259D$320.888(17)42,581(2)D
Common Stock08/19/2026S(1)3,988D$321.988(18)38,593(2)D
Common Stock08/19/2026S(1)3,711D$322.877(19)34,882(2)D
Common Stock08/19/2026S(1)3,895D$324.128(20)30,987(2)D
Common Stock08/19/2026S(1)2,392D$324.875(21)28,595(2)D
Common Stock08/19/2026S(1)60D$325.8228,535(2)D
Common Stock16,300ITrust(22)
Common Stock78,893ITrust(23)
Common Stock56,331ITrust(24)
Common Stock56,331ITrust(25)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.8808/18/2026M(1)251,010 (26)05/28/2029Common Stock251,010$04,485,645D
Stock Option (Right to Buy)$8.8808/19/2026M(1)48,990 (26)05/28/2029Common Stock48,990$04,436,655D
Explanation of Responses:
1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $321.620 to $322.605, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $322.620 to $323.615, inclusive.
5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $323.620 to $324.610, inclusive.
6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $324.620 to $325.617, inclusive.
7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $325.620 to $326.560, inclusive.
8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $326.620 to $327.590, inclusive.
9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $327.725 to $328.660, inclusive.
10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $328.730 to $329.480, inclusive.
11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.860 to $330.830, inclusive.
12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.880 to $331.850, inclusive.
13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.995 to $332.920, inclusive.
14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.200 to $334.000, inclusive.
15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $318.510 to $319.500, inclusive.
16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $319.510 to $320.495, inclusive.
17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $320.520 to $321.510, inclusive.
18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $321.525 to $322.510, inclusive.
19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $322.530 to $323.460, inclusive.
20. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $323.655 to $324.545, inclusive.
21. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $324.755 to $325.590, inclusive.
22. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
23. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
24. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
25. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
26. The stock option is fully vested.
Remarks:
/s/ Marie Reider, Attorney-in-Fact08/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR